Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCV, HIV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01565889
What this trial is testing

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Who this might be right for
Hepatitis CHIV
Gilead Sciences 52
Not applicableUnknownNCT05293821
What this trial is testing

Multicenter Performance Study of TriQuik Invitro Diagnostic Device

Who this might be right for
To Demonstrate Clinical Performance of the TriQuik Invitro Diagnostic Device
Genlantis Diagnostics 200
Not applicableStudy completedNCT01844414
What this trial is testing

UCLA-Amity Parolee Health Promotion Study

Who this might be right for
Hepatitis BHepatitis CHIV+1 more
University of California, Los Angeles 600
Not applicableStudy completedNCT02869776
What this trial is testing

Integrating HCV and HIV Screening During the Era of HIV Antigen Testing

Who this might be right for
HIVHepatitis C
Boston Medical Center 200
Early research (Phase 1)Study completedNCT01627717
What this trial is testing

The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

Who this might be right for
Healthy
Centre hospitalier de l'Université de Montréal (CHUM) 11
Not applicableStudy completedNCT00006643
What this trial is testing

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 44
Post-approval studies (Phase 4)Study completedNCT00470210
What this trial is testing

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Who this might be right for
Hepatitis CHIV Infections
Germans Trias i Pujol Hospital 10
Not applicableStudy completedNCT05208697
What this trial is testing

Tele-Harm Reduction

Who this might be right for
IV Drug UsageHIV InfectionsHepatitis C
University of Miami 100
Testing effectiveness (Phase 2)WithdrawnNCT02306070
What this trial is testing

Improving Fibrosis Outcomes With Metformin

Who this might be right for
HIV InfectionHepatitis C
Ottawa Hospital Research Institute
Not applicableStudy completedNCT05286879
What this trial is testing

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

Who this might be right for
Opioid Use DisorderInfectious DiseaseRisk Reduction Behavior+3 more
Yale University 601
Not applicableStudy completedNCT04048850
What this trial is testing

Zepatier in Patients with Substance Use

Who this might be right for
Hepatitis CHivCoinfection, HIV+1 more
University of Illinois at Chicago 25
Early research (Phase 1)Study completedNCT00879047
What this trial is testing

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Who this might be right for
HIV InfectionsHepatitis C
University of California, San Francisco 30
Not applicableLooking for participantsNCT05968573
What this trial is testing

Persuasive Health Communication Intervention for HIV/HCV

Who this might be right for
Human Immunodeficiency Virus (HIV)Hepatitis C (HCV)
University of South Florida 2,000
Post-approval studies (Phase 4)Study completedNCT02533934
What this trial is testing

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

Who this might be right for
HIVHepatitis CCirrhosis
University of California, San Francisco 68
Testing effectiveness (Phase 2)Study completedNCT00221650
What this trial is testing

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected Patients

Who this might be right for
HIV InfectionsHepatitis C, ChronicTreatment Failure
University Hospital, Bordeaux 17
Post-approval studies (Phase 4)Study completedNCT00866021
What this trial is testing

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Who this might be right for
HIV/HCV Co-infectionHIV Infections
Fundacion SEIMC-GESIDA 68
Not applicableStudy completedNCT00552214
What this trial is testing

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Who this might be right for
Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations
Novartis 10,290
Testing effectiveness (Phase 2)UnknownNCT00225537
What this trial is testing

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
MTmedical Institute of Health 160
Large-scale testing (Phase 3)Ended earlyNCT00296972
What this trial is testing

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Who this might be right for
Chronic Hepatitis CHIV Infections
University Health Network, Toronto 100
Not applicableStudy completedNCT00004846
What this trial is testing

Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

Who this might be right for
Hepatitis CHIV Infection
National Institutes of Health Clinical Center (CC) 30,000
Next Page